ApprovalTrail

Drug · DIN 02374285 · Radiopharmaceutical

RUBY-FILL

Yes: authorized and sold in Canada

Authorized, and the company reports that it sells it in Canada.

Status Marketed since September 17, 2018; first marketed September 20, 2011.
Drug Identification Number (DIN)
02374285
Company (DIN owner)
Jubilant Draximage Inc.Kirkland, Quebec, Canada
Schedule
Schedule c
Dosage form
Solution
Route
Intravenous
Class
Radiopharmaceutical
Record last updated
March 22, 2025

Active ingredients

As listed in the Drug Product Database.

IngredientStrengthPer
RUBIDIUM CHLORIDE RB 823.7 GBQGEN

Recalls and safety alerts that mention it

Health Canada’s recall notices do not carry licence numbers, so these are matched by name: notices whose title or product names “ruby-fill”. A notice may cover another product or only some lots: read it to see what it covers.